Seeking Alpha

Analysts weigh in on Clorox

  • Estimates on Clorox (CLX -2.6%) are being taken lower by investment firms after the company's FQ4 sales read came in light.
  • Credit Suisse stays with its Underperform stance, saying Clorox's organic sales will only grow in the low single-digits
  • B. Riley lowers its FY15 EPS guidance to $4.40, below the mid-point of Clorox's guidance.
  • Citigroup is taking the long view on Clorox to stick with a Buy rating despite the short-term profit hiccups.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs